Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives

被引：51
作者：
de Almeida, Mauro V.
Saraiva, Mauricio F.
de Souza, Marcus V. N.
da Costa, Cristiane F.
Vicente, Felipe R. C.
Lourenco, Maria C. S.
机构：
[1] Univ Fed Juiz Fora, Inst Ciencias Exatas, Dept Quim, BR-36036330 Juiz De Fora, MG, Brazil
[2] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos Far Manguinhos, BR-21041250 Rio De Janeiro, Brazil
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 20期
关键词：
Fluoroquinolones; M; tuberculosis; moxifloxacin; gatifloxacin; diamines; N-alkyl chains; antitubercular; structure-activity relationships;
D O I：
10.1016/j.bmcl.2007.07.073
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Fluoroquinolone (FQ) has a broad spectrum of activity against several bacteria, mycobacteria, parasites, and other diseases. Moxifloxacin and gatifloxacin are a new generation of fluoroquinolone agents with improved activity against Gram-negative and positive bacteria. As lipophilicity is an important consideration in the design and activity of novel antibacterial agents, we report in this work the synthesis and biological evaluation of 12 lipophilic moxifloxacin or gatifloxacin derivatives, by reaction of 1-cyclo-propyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid 13 with severals N-monoalkyl 1,2-ethanediamine or 1,3-propanediamine. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5661 / 5664
页数：4
相关论文
共 20 条
  • [1] Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes
    Aldridge, KE
    Ashcraft, DS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 709 - 711
  • [2] ALMEIDA MV, 2007, IN PRESS EUR J MED C
  • [3] Mycobacterium tuberculosis DNA gyrase:: Interaction with quinolones and correlation with antimycobacterial drug activity
    Aubry, A
    Pan, XS
    Fisher, LM
    Jarlier, V
    Cambau, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1281 - 1288
  • [4] THE ENVELOPE OF MYCOBACTERIA
    BRENNAN, PJ
    NIKAIDO, H
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 : 29 - 63
  • [5] Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
    Collins, LA
    Franzblau, SG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1004 - 1009
  • [6] Biological activity and synthetic metodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents
    Da Silva, AD
    De Almeida, MV
    De Souza, MVN
    Couri, MRC
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (01) : 21 - 39
  • [7] 3-[4′-Bromo-(1,1′-biphenyl)-4-yl]-N,N-dimethyl-3-(2-thienyl)-2-propen-1-amine:: synthesis, cytotoxicity, and leishmanicidal, trypanocidal and antimycobacterial activities
    de Souza, AO
    Hemerly, FP
    Busollo, AC
    Melo, PS
    Machado, GMC
    Miranda, CC
    Santa-Rita, RM
    Haun, M
    Leon, LL
    Sato, DN
    de Castro, SL
    Durán, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) : 629 - 637
  • [8] Fluoroquinolones: An important class of antibiotics against tuberculosis
    De Souzaa, MVN
    Vasconcelos, TRA
    de Almeida, MV
    Cardoso, SH
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (04) : 455 - 463
  • [9] DESOUZA MVN, 2006, EUR J MED CHEM, V41, P1478
  • [10] DNA gyrase, topoisomerase IV, and the 4-quinolones
    Drlica, K
    Zhao, XL
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) : 377 - +
12